T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gabrielle Meyers, MD
Oregon Health and Science University
Study Chair - John Levine, MD
Icahn School of Medicine at Mount Sinai
Study Chair - Mehdi Hamadani, MD
Medical College of Wisconsin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas
Westwood, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of Nebraska
Omaha, Nebraska, United States
- Mount Sinai Medical Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2019
- Primary completion
- 17 Feb 2020
- Completion
- 17 Feb 2020
- Last update posted
- 16 Dec 2021
- Registered enrollment
- 3
- Registry id
- NCT04128319
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.